Inactive Instrument

RISE Life Science Corp. Share Price

RLSC

CA76761F1053

Latest news: RISE Life Science Corp.

12/21/12	Britannia Bud Canada Holdings Inc. completed the acquisition of RISE Life Science Corp. in a reverse merger transaction.	CI
02/21/02	RISE Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	CI
30/21/30	Scientus Pharma Inc. cancelled the acquisition of RISE Life Science Corp. in a reverse merger transaction.	CI
01/21/01	RISE Life Science Corp. Appoints Greg Taylor as Board of Director	CI
30/21/30	RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	CI
29/21/29	Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	CI
15/21/15	RISE Life Science Corp. announced that it has received $1.331 million in funding	CI
30/21/30	Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2020	CI
04/21/04	RISE Life Science Corp. announced that it expects to receive $0.71 million in funding	CI
22/21/22	Britannia Bud Canada Holdings Inc. entered into a Letter of intent to acquire RISE Life Science Corp. in a reverse merger transaction.	CI
31/20/31	Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2020	CI
29/20/29	Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2020	CI
13/20/13	RISE Life Science Corp. announced that it expects to receive CAD 10 million in funding	CI

More news

Press Releases: RISE Life Science Corp.

18/21/18	IIROC Trade Resumption - BLAB	AQ
15/21/15	Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.	AQ
02/21/02	RISE Life Science : Greg Taylor Joins the Board of RISE Life Science Corp.	AQ
11/21/11	RISE Life Science Corp :. Announces Conversion of Debentures and Debt Settlement	AQ
03/21/03	Britannia Enters into Definitive Agreement with Rise Life Science to "Go Public" via Reverse Takeover of Rise Life Science	NE

More press releases

Special Foods & Wellbeing Products

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RISE LIFE SCIENCE CORP.	+100.00%	+700.00%	-	-	96.83L
NESTLÉ S.A.	0.00%	-0.79%	+4.35%	-15.03%	26TCr
MONDELEZ INTERNATIONAL, INC.	+1.07%	-4.08%	+8.09%	-5.23%	7.9TCr
DANONE	+1.80%	+5.85%	-17.52%	+16.69%	4.53TCr
ARCHER-DANIELS-MIDLAND COMPANY	-1.33%	-4.56%	+25.91%	+6.69%	3.72TCr
THE HERSHEY COMPANY	-2.13%	-8.75%	-8.56%	-13.82%	3.29TCr
AJINOMOTO CO., INC.	+0.18%	-2.65%	+21.44%	+86.46%	3.09TCr
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	+3.20%	+3.20%	-10.08%	-7.50%	2.88TCr
KRAFT HEINZ	+0.17%	-4.74%	-1.97%	-24.41%	2.83TCr
INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.	+2.65%	+6.70%	+7.99%	+9.56%	2.72TCr
Average	+11.06%	-0.01%	+3.29%	+5.94%	6.29TCr
Weighted average by Cap.	+0.78%	-0.41%	+3.85%	-2.99%

See all sector performances

Britannia Life Sciences Inc, formerly RISE Life Science Corp, is a Canada-based vertically diversified product development company. The Company's platform provides an integrated, one-stop shop service for product development, testing, safety & compliance and consumer evaluations/trials. Its principal activities include quality ingredients, formulations, safety assessment, analytical & quality assessments, global compliance and regulation, consumer trials and evaluations for various sectors. It serves Consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

Employees

Sector

Food Processing

More about the company